CC, L., YS, C., NY, L., HJ, T., SSJ, L., CF, L., . . . PR, H. (2019, March). Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). Infection and Drug Resistance.
Chicago Style (17th ed.) CitationCC, Lai, et al. "Susceptibility Rates of Clinically Important Bacteria Collected from Intensive Care Units Against Colistin, Carbapenems, and Other Comparative Agents: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)." Infection and Drug Resistance Mar. 2019.
MLA (9th ed.) CitationCC, Lai, et al. "Susceptibility Rates of Clinically Important Bacteria Collected from Intensive Care Units Against Colistin, Carbapenems, and Other Comparative Agents: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)." Infection and Drug Resistance, Mar. 2019.
